Pacylex Pharmaceuticals
CEO
Pursuing initial Seed funding round and preparing for pre-IND meeting.
Michael Weickert
CEO Pacylex, former CEO Sonescence & SEA Medical, CBO Corium, Therashock & StrataGent, VP Auspex, SciDose, Sr. Exec. Nektar, Ligand, Somatogen, PhD U. Wisconsin
CEO Pacylex, former CEO Sonescence & SEA Medical, CBO Corium, Therashock & StrataGent, VP Auspex, SciDose, Sr. Exec. Nektar, Ligand, Somatogen, PhD U. Wisconsin
There was a problem loading your content.
Experience
Wit Creek Partners
Founder, President
Strategic product and business consulting and advising to help startups and established companies define business objectives and products, initiate and accelerate projects,... more secure financing, and help investors identify profitable opportunities in pharmaceuticals, biotech, medical devices and drug delivery.
♦ Write business plans and pitch decks
♦ Strategic planning
♦ Product Selection
♦ Combination Products
♦ Evaluate technology and products
♦ Conduct or prepare for investor diligence
♦ Write business plans and pitch decks
♦ Strategic planning
♦ Product Selection
♦ Combination Products
♦ Evaluate technology and products
♦ Conduct or prepare for investor diligence
Sonescence
President and CEO
♦ Reestablishing ownership and commercial rights.
♦ Expanded exposure to thought leaders and visibility with potential investors through positioning of multiple posters... more and talks at prominent international meetings.
♦ Laid groundwork for development partnerships by initiating discussions with 8 prominent researchers and leading negotiations.
♦ Secured Seed funding and investment package offer to drive IPO within 12-18 months.
♦ Expanded exposure to thought leaders and visibility with potential investors through positioning of multiple posters... more and talks at prominent international meetings.
♦ Laid groundwork for development partnerships by initiating discussions with 8 prominent researchers and leading negotiations.
♦ Secured Seed funding and investment package offer to drive IPO within 12-18 months.
S.E.A. Medical Systems
Founder, CEO, President, Chairman of the Board, co-founder
Created business plans and strategy, built the company management team, drove marketing, and obtained Seed through Series B financings.
♦ Transformed product concept into... more portfolio of 4 intravenous products.
♦ Cleared FDA hurdles, including obtaining 513(g) clearance to enable marketing initial product without FDA approval.
♦ Attracted multimillion dollar strategic partnership, VC deals, and successful financing of the company in-full, from Seed through raising over $12 million in total.
♦ Transformed product concept into... more portfolio of 4 intravenous products.
♦ Cleared FDA hurdles, including obtaining 513(g) clearance to enable marketing initial product without FDA approval.
♦ Attracted multimillion dollar strategic partnership, VC deals, and successful financing of the company in-full, from Seed through raising over $12 million in total.
Auspex Pharmaceuticals
Vice President Development
Creating a strong pipeline with solid business rationale for future company development, Dr. Weickert planned and led early development of Auspex’s flagship product, a deuterated... more CNS/psych pharmaceutical. He also orchestrated selection and prioritization of additional products to enhance the company's portfolio.
Nektar Therapeutics
Senior Program Executive, Senior Director Product Marketing, New Product Planning, Program Mgt.
Propelled Nektar’s transformation into a proprietary products company. Spearheaded internal startup initiatives, acquisitional integrations, and drove a flagship product from... more pre-clinical start through Phase 2 development. With his team, he screened hundreds of business opportunities and wrote dozens of business plans. His work for Nektar set the stage for a $115 million acquisition by Novartis in 2008, plus other key initiatives and spin-off companies.
♦ Led team of 120+ people, $20M budget
♦ Led team of 120+ people, $20M budget
Founder
Employee
Advisor
Education
About
Achievements
Personally initiated and negotiated investment rounds (Seed through Series C) and partnerships worth more than $175 Million
Grew SEA Medical from inception to 26 employees and $5M in revenue
Created an anti-infectives business unit that placed four drug delivery products in development and formed the core of the $115M pulmonary business acquisition by Novartis in 2008
Worked with Business Development partnering in US, EU and Japan
At Ligand Pharmaceuticals, Somatogen and Nektar, he led the development of small molecule, biologic and drug delivery products respectively
Prepared business and marketing plans for a Nobel Prize winner’s startup and several other Venture-backed startups and for profitable companies
“Best Presenter" out of 81 companies participating in the 13th annual New York Venture Summit, 2013
Authored or co-authored 23 peer-reviewed scientific publications
Wrote, co-wrote or edited successful packages for US and EU orphan drug, waivers, Fast Track & pre-meeting packages
Skills
Locations
Q&A
What words of advice would you give your younger self?
Take the great opportunity that presents itself; it is not a signal to wait for something better.
What's the most creative thing you've ever done?
Solving a problem that saved a company in one weekend.
What's your super power?
Making a simple and compelling narrative from complicated inputs.
What's the best way for people to get in touch with you?
[email protected] if you don't know me, call if you do.
What words of wisdom do you live by?
Keep moving forward.